- Home
- SWBI vs SIGA Comparison
SWBI vs SIGA Comparison
Compare SWBI & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWBI
- SIGA
- Stock Information
- Founded
- SWBI 1852
- SIGA 1995
- Country
- SWBI United States
- SIGA United States
- Employees
- SWBI N/A
- SIGA N/A
- Industry
- SWBI Ordnance And Accessories
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- SWBI Industrials
- SIGA Health Care
- Exchange
- SWBI Nasdaq
- SIGA Nasdaq
- Market Cap
- SWBI 429.0M
- SIGA 422.9M
- IPO Year
- SWBI N/A
- SIGA 1997
- Fundamental
- Price
- SWBI $8.54
- SIGA $6.77
- Analyst Decision
- SWBI Buy
- SIGA
- Analyst Count
- SWBI 2
- SIGA 0
- Target Price
- SWBI $12.00
- SIGA N/A
- AVG Volume (30 Days)
- SWBI 1.3M
- SIGA 382.0K
- Earning Date
- SWBI 09-04-2025
- SIGA 07-31-2025
- Dividend Yield
- SWBI 6.09%
- SIGA 8.70%
- EPS Growth
- SWBI N/A
- SIGA N/A
- EPS
- SWBI 0.30
- SIGA 0.67
- Revenue
- SWBI $474,661,000.00
- SIGA $120,330,310.00
- Revenue This Year
- SWBI $8.53
- SIGA N/A
- Revenue Next Year
- SWBI N/A
- SIGA $95.31
- P/E Ratio
- SWBI $28.47
- SIGA $10.28
- Revenue Growth
- SWBI N/A
- SIGA N/A
- 52 Week Low
- SWBI $8.38
- SIGA $4.95
- 52 Week High
- SWBI $16.85
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- SWBI 36.14
- SIGA 61.28
- Support Level
- SWBI $8.53
- SIGA $6.34
- Resistance Level
- SWBI $8.85
- SIGA $7.07
- Average True Range (ATR)
- SWBI 0.23
- SIGA 0.22
- MACD
- SWBI -0.04
- SIGA 0.02
- Stochastic Oscillator
- SWBI 20.54
- SIGA 71.70
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.